Rare Disease Drug Discovery Program
Undisclosed Rare Diseases
PreclinicalActive
Key Facts
About RevolKa
RevolKa uses AI-driven protein engineering to accelerate the development of novel biopharmaceuticals and industrial enzymes.
View full company profileTherapeutic Areas
Other Undisclosed Rare Diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| JOTROL™ | Jupiter Neurosciences | Clinical |
| rAAV-based Gene Therapy Programs | Takara Bio | Discovery / Preclinical |